AI assistant
Merck & Co., Inc. — Director's Dealing 2025
May 2, 2025
284_dirs_2025-05-01_915ed101-498e-4a9a-a6a8-8f542d2ac810.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2025-04-29
Reporting Person: DeLuca Richard R. (EVP&Pres, Merck Animal Heallth)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-04-29 | Restricted Stock Unit | $ | A | 7555 | Acquired | 2028-04-29 | Common Stock (7555) | Direct |
| 2025-04-29 | Stock Option (Right to Buy) | $84.71 | A | 34390 | Acquired | 2035-04-28 | Common Stock (34390) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 180729.7 | Direct |
| Common Stock - 401(k) Plan | 1281.1964 | Indirect |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: Includes shares acquired and dividends earned through April 7, 2025 in the Merck U.S. Savings Plan, a 401(k) plan.
F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
F5: The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.